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ABSTRACT 
Objectives: The progression of human immunodeficiency virus 
(HIV) disease varies considerably among infected people, being 
affected by factors such as virus characteristics, host response, 
and their interactions. Some patients with HIV may remain clin- 
ically and immunologically well for an extended period. This 
study aims to describe the frequency and demographic features 
of a group of HIV-I positive nonprogressors in Hong Kong. 
Method: A retrospective study was conducted of records of a 
cohort of 58 HIV-I positive patients infected for over 7 years 
in Hong Kong. Nonprogression is defined as the maintenance 
of health with no symptoms and a CD4 level of 50O/f.~L or 
higher. 
Results: Twenty-five patients had progressed to acquired im- 
munodeficiency syndrome (22 died); 3 had had other HIV- 
related symptoms; 22 were asymptomatic but had CD4 lower 
than 5OO/uL; and 8 (13.8%) were nonprogressors with no 
symptoms and CD4 count higher than 5OO/uL (median of 
665/pL an average of 102.5 months after HIV detection). The 
nonprogressors had a relatively high CD8 level. Hemophilia with 
transfusion of HIV-contaminated blood products accounted for 
100% of all nonprogressors, and’58% of those with clinical or 
immunologic progression (P = 0.041). 
Conclusion: These findings indicate that a proportion of HIV- 
infected individuals do not progress clinically or immunologically 
over a prolonged period. To date, all nonprogressors known to 
the authors are patients with hemophilia. 
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Acquired immunodeficiency syndrome (AIDS) and infec- 
tion by its causative agent, human immunodeficiency virus 
(HIV), have resulted in significant morbidity and mortality 
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The natural history and rate of HIV infection progression, 
however, is known to vary considerably The exact mech- 
anisms leading to the wide spectrum of disease manifes- 
tations, from asymptomatic stage to late clinically and 
immunologically progressive stage, is largely undetermined. 
Postulations have been made on multiple factors, such as 
virus characteristics, host factors, their interactions, and 
other confounding variab1es.l 
It is generally believed that all HIV-positive patients 
will progress to AIDS with time, with a majority devel- 
oping HIV-related symptoms or disease within several 
years.2,3 However, recent reports suggest that there exists 
a group of patients who remain healthy and immuno- 
logically well (i.e., no declining CD4 level) for an extended 
period.4-6 This study describes the frequency and demo- 
graphic features of a group of HIV-l positive nonprogres- 
sors in Hong Kong. 
SUBJECTS AND METHODS 
It is not mandatory to report HIV infection or AIDS in 
Hong Kong. A voluntary reporting system has been 
adopted for epidemiologic and statistical reasons, since 
the diagnosis of the first case of HIV infection in late 
1984. This retrospective study is based on HIV-positive 
subjects reported to the Department of Health from 19% 
to 1987 (i.e., infected for 2 7 years as of December 1994). 
Records were retrieved, and demography, clinical pro- 
gression, immunologic status, and medical intervention 
of the patients were studied. Patients with insufficient 
data, or whose outcome was not clear 7 years after HIV 
detection were excluded from the study. Nonprogression 
was defined as the maintenance of health with no symp- 
toms,’ and CD4 level of 500&L or higher at the end of 
the study. Statistical comparisons of groups were made 
with Fisher’s exact test (2-tailed), chi-square test, one- 
way ANOVA (analysis of variance) or Wilcoxon rank-sum 
test where appropriate. A P value of < 0.05 was taken to 
be statistically significant. 
RESULTS 
A total of 106 patients were known to have acquired 
HIV-l infection in or before 1987. HIV-2 infection was not 
reported during the period. Forty-eight patients were lost 
to follow-up, or insufficient data were available at the 
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time of the study, and they were excluded. The remain- 
ing 58 patients formed the cohort of the study. There 
was no significant distribution difference in sex between 
the excluded and the studied group. However, statisti- 
cally significant differences existed for the proportion of 
patients with hemophilia (64% vs. 35%, P = 0.006) and 
homosexual/bisexual contacts (26% vs. 48%, P = 0.025) 
who were included or excluded from the study. Also, sig- 
nificantly more of the studied patients were ethnic Chi- 
nese (P = 0.002) and of younger age at HIV detection 
(P = 0.042). Demographic data for the 58 studied patients 
are shown in Table 1. Regarding their clinical and 
immunologic outcomes, three groups of patients were 
identified: (1) clinical progressors: symptomatic with 
AIDS or other HIV-related diseases, (2) asymptomatic 
immunologic progressors with CD4 count below 500/I.~L 
and, (3) nonprogressors: asymptomatic with CD4 count 
higher than 50O/l.~L. The changes in CD4 level over the 
course of HIV infection for three patients with different 
rates of progression are shown in Figure 1. 
Clinical Progressors 
Of the 58 patients, 28 could be classified as clinical pro- 
gressors. Twenty-five (43%) had developed AIDS and 22 
had died. Nearly 70% of them were known to have 
received antiviral drugs (mainly zidovudine monotherapy 
and some combination therapy with ddI/ddC) and Pneur 
mocystis carinii pneumonia (PCP) prophylaxis (oral co- 
trimoxazole or aerosol pentamidine). The mean duration 
from HIV diagnosis to AIDS was 35 months (range O-108 
mo). The major AIDS-defining diseases were PCP (28%) 
extrapulmonary tuberculosis (16%) and Kaposi’s sarcoma 
(12%). The median CD4 and CDS counts at AIDS diagno- 
sis were 122/pL (range, 12-650/p~) and 472/pL (range, 
40-3025/pL), respectively. Pneumocystis carinii pneu- 
monia and Mycobacterium avium complex accounted 
for 43% of the known causes of death. Three patients had 
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Figure 1. CD4 profiles of three patients with different rates of 
progression. NP = nonprogressor, AIP = asymptomatic immunologic 
progressor, CP = clinical progressor. 
Table 1. Demographic Characteristics of the Progressors 
and Nonprogressors 
Demographic 
Characteristic 
Asymptomatic 
Clinical Immunologic 
Progressors Progressors Nonprogressors 
(n = 28) (n = 22) (n = 8) 
Sex (M:F) 26:2 22:o 8:0 
Chinese:non-Chinese 21:7 21:l 7:l 
Age at HIV Diagnosis 
Mean (Y) 28.6 19 18.6 
Range (Y) 4-67 2-38 3-35 
Risk Factor 
Hemophilia n (%) 10 (36) 19 (86) a (100) 
Blood transfusion n (%) 1 (4) - 
Homosexual/bisexual n (%) 12 (43) 3 (14) - 
Heterosexual n (%) 3(10) - - 
Unknown n (%) 2 (7) - - 
not yet progressed to AIDS, but developed oral thrush due 
to underlying immunodeficiency. Two were hemophiliacs 
and one had been infected through blood transfusion. They 
had low CD4 count (i.e., 4, 128, 154&L) at a mean of 117 
months from HIV detection. 
Asymptomatic Immunologic Progressors 
Twenty-two patients (37.9%) were asymptomatic immuno- 
logic progressors. They were free of HIV-related symp- 
toms. Nine were known to have received AZT, and three 
PCP prophylaxis. Their latest median CD4 and CDS counts 
were 328/p,L (range, 183-484/uL) and 785/pL (range, 
245-1276/kL), respectively, an average of 105 months after 
HIV diagnosis. The median CD4:CDS ratio was 0.46. 
Nonprogressors 
Eight (13.8%) persons met the definition of nonprogres- 
sors used in this study. They had a median CD4 count of 
665/pL, an average of 102.5 months after HIV diagnosis. 
The corresponding median CDS count was 1035/pL, giv- 
ing a CD4:CDS ratio of 0.69. The latest CDS counts of 
nonprogressors were higher than those of asymptomatic 
immunologic progressors, although the difference did 
not reach statistical significance (P = 0.056). However, the 
nonprogressors had a significantly higher CD4:CDS ratio 
(P = 0.004). 
There was no statistically significant difference in 
ethnic&y, sex, or age at HIV diagnosis when comparing 
nonprogressors with all other patients. Nevertheless, the 
mean age of clinically asymptomatic subjects (nonpro- 
gressors and asymptomatic immunologic progressors) 
was lower than that of symptomatic subjects (18.9 y vs. 
28.6 y), and this difference was statistically significant 
(P = 0.006). All of the nonprogressors and 29 (58%) of 
the group of clinical or immunologic progressors were 
hemophiliacs (P = 0.022). The difference in the propor- 
tion with hemophilia was even more evident when com- 
paring clinically asymptomatic subjects with symptomatic 
patients (P < 0.001). 
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DISCUSSION 
Human immunodeficiency virus infection demonstrates 
the remarkably varied manifestations of an infectious 
disease. The variable rate of clinical and immunologic 
progression in the natural course of HIV disease has 
prompted researchers to investigate the factors govern- 
ing disease progression. Recent reports of the existence 
of a group of HIV-infected nonprogressors was an excit- 
ing development. Different terms and criteria have been 
used in the study of nonprogression of HIV disease. The 
term nonprogressor is usually given to those infected for 
5 to 10 years, and a combination of clinical and CD4 cri- 
teria are often required. Common clinical criteria used 
include being free of AIDS, not having HIV-related symp- 
toms,’ and not having received any antiviral agents8 The 
immunologic criteria commonly used was a CD4 count 
of 50O/l.~L or higher,7-9 or no net loss of CD4 cells over 
time.5 The incidence of nonprogressors ranged from 5 
to 15% in various studies.8-10 
In this study, the majority of local HIV-infected 
patients diagnosed before 1987 belonged to the trans- 
mission category of either hemophilia or homosexual/ 
bisexual contacts. The criteria of 7 or more years of HIV 
infection, being free of symptoms, and also having a CD4 
count higher than 500/~L for nonprogression was cho- 
sen to study this group of patients diagnosed early in the 
epidemic. From the cohort with known outcome, 13.7% 
were classified as nonprogressors, which was a relatively 
high rate. The lower limit would be 7.5% if the total mm- 
ber of patients (106) diagnosed in that period was taken 
as the denominator. These figures were comparable to 
those reported elsewhere.8-10 
It is interesting to note that all nonprogressors in the 
current study were hemophiliacs. It has been suggested 
that the progression to AIDS of HIV-infected hemophilia 
patients may be slower than that of patients in other 
exposure categories. l1 In addition, several studies have 
found that older age at time of seroconversion is associ- 
ated with a faster progression rate toward AIDS in hemo- 
philiac and homosexuals. 12,13 A younger age at time of 
HIV detection in the clinically asymptomatic subjects was 
also noted in the current study. The finding that all non- 
progressors were hemophiliacs may also have arisen 
because of selection bias, since a majority of HIV-positive 
patients diagnosed before 1987 were recipients of con- 
taminated blood or blood products. Furthermore, relatively 
more data were available on HIV-infected hemophiliacs 
because of the medical, social, and financial assistance 
package offered to them in Hong Kong.14 Therefore, a sig- 
nificantly greater proportion of the HIV-infected hemo- 
philia patients were included in the study. Significantly 
more homosexual or bisexual men were included rather 
than excluded. The significance of having more Chinese 
subjects and younger patients at HIV detection has not 
been determined. 
There has been conflicting, but largely unsupported 
evidence that life-style can accelerate the progression of 
HIV infection. For example, there is no difference in the 
use of recreational drugs, or acquisition of certain sexu- 
ally transmitted diseases between nonprogressors and 
progressors.9 Neither were the number of lifetime sexual 
partners nor the frequency of specific sexual activities 
correlated with slower progression in homosexuals and 
bisexuals.9 Viral and immunologic factors may be more 
important in determining rate of progression. Continued 
viral replication but a low viral load, and intact immune 
function and lymph node architecture have been found 
in nonprogressors. l5 Strong virus-specific immune 
response (both humoral and cell-mediated) and possibly, 
some degree of viral attenuation may also contribute to 
nonprogression. l6 In the current study, nonprogressors 
had a high CDS count, which was compatible with other 
studies that found high CDS levels and sustained CDS-cell 
activity correlated with nonprogression.9z10 The impor- 
tance of virus characteristics was exemplified by the 
report of nonprogression in an HIV-positive blood donor 
and his six recipients. l7 iVef gene deletion in simian 
immunodeficiency virus and its resulting low viral load 
and absence of clinical disease in monkeys may also be 
important clues regarding factors determining HIV pro- 
gression in humans.18 
Previous studies on nonprogression have focused 
mainly on HIV-infected homosexuals. It is possible that 
similar factors for nonprogression are operating in 
patients infected by other routes of transmission (e.g., 
hemophiliacs), as was noted in this study However, the 
incidence of nonprogression found in this study may be 
an under- or over-estimate of the true figure, depending 
on the status of the missing patients. Many homosexual 
patients with HIV infection of 7 years or longer duration 
were not included in the cohort analysis. Some non- 
progressors may have been found among these patients 
if their outcome and data had been available. The signi- 
ficance of transmission route could be determined if 
patients diagnosed after 1987 were monitored for a suffi- 
ciently long period. 
In summary, the current study supports the observa- 
tion that a proportion of HIV-infected individuals can 
remain clinically healthy with stable CD4 count over a 
prolonged period. This phenomenon is likely to be the 
result of interactions of heterogeneous and complicated 
variables. The nonprogressors may represent the tail-end 
of a continuous spectrum of progression, or alternatively 
they may truly be nonprogressors who will remain well 
for their lifetime. All HIV-positive nonprogressors included 
in this study are hemophilia patients. The relation between 
the rate of progression and the routes of transmission 
would need to be determined by larger studies over an 
extended period. 
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